LOIZZI, VERA
 Distribuzione geografica
Continente #
NA - Nord America 9.581
EU - Europa 2.439
AS - Asia 1.268
SA - Sud America 14
OC - Oceania 11
AF - Africa 7
Continente sconosciuto - Info sul continente non disponibili 5
Totale 13.325
Nazione #
US - Stati Uniti d'America 9.559
CN - Cina 782
SE - Svezia 617
UA - Ucraina 442
IT - Italia 420
SG - Singapore 383
DE - Germania 316
FI - Finlandia 232
FR - Francia 146
GB - Regno Unito 141
IE - Irlanda 36
BE - Belgio 35
IN - India 31
CA - Canada 22
VN - Vietnam 22
IR - Iran 13
CZ - Repubblica Ceca 12
LT - Lituania 9
AU - Australia 8
JP - Giappone 8
NL - Olanda 8
BR - Brasile 7
RU - Federazione Russa 7
KR - Corea 6
EU - Europa 5
TR - Turchia 4
AM - Armenia 3
ES - Italia 3
HK - Hong Kong 3
NZ - Nuova Zelanda 3
PK - Pakistan 3
SA - Arabia Saudita 3
AR - Argentina 2
CL - Cile 2
EC - Ecuador 2
HU - Ungheria 2
LU - Lussemburgo 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
SY - Repubblica araba siriana 2
TN - Tunisia 2
ZA - Sudafrica 2
AT - Austria 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
CO - Colombia 1
DZ - Algeria 1
EG - Egitto 1
GR - Grecia 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
MA - Marocco 1
MD - Moldavia 1
MY - Malesia 1
PL - Polonia 1
SI - Slovenia 1
UZ - Uzbekistan 1
Totale 13.325
Città #
Fairfield 1.087
Chandler 1.031
Jacksonville 959
Woodbridge 699
Ashburn 642
Houston 564
Cambridge 492
Nyköping 477
Seattle 465
Ann Arbor 410
Wilmington 385
Singapore 286
Lawrence 242
Roxbury 235
Nanjing 197
New York 154
Des Moines 149
Beijing 137
Boardman 135
Bari 130
Princeton 119
Dearborn 68
Inglewood 66
Hebei 60
Shenyang 58
San Diego 57
Nanchang 48
Santa Clara 48
Jiaxing 45
Dublin 36
Los Angeles 36
Brussels 35
Tianjin 35
Brooklyn 31
Matera 29
Washington 28
Paris 27
London 26
Helsinki 24
Changsha 22
Dong Ket 21
Milan 21
Guangzhou 18
Pune 18
Toronto 16
Falls Church 15
Redwood City 15
Hefei 13
Shanghai 13
Marseille 12
Kunming 11
Lissone 11
Auburn Hills 10
Munich 10
San Francisco 10
Brno 9
Zhengzhou 9
Fasano 8
Norwalk 8
Wuhan 8
Chiswick 7
Frankfurt am Main 7
Ardabil 6
Indiana 6
Jinan 6
San Mateo 6
Taranto 6
Chongqing 5
Cosenza 5
Edinburgh 5
Fuzhou 5
Hangzhou 5
Ostuni 5
Rome 5
Savigliano 5
St Louis 5
Tokyo 5
Acton 4
Augusta 4
Barletta 4
Canberra 4
Kilburn 4
Leawood 4
Ottawa 4
Palermo 4
Redmond 4
Simi Valley 4
Southwark 4
Triggiano 4
Baotou 3
Chengdu 3
Hanover 3
Hisings Backa 3
Hounslow 3
Islamabad 3
Jinhua 3
Melbourne 3
Naples 3
Ningbo 3
Olomouc 3
Totale 10.205
Nome #
The Crowded Crosstalk between Cancer Cells and Stromal Microenvironment in Gynecological Malignancies: Biological Pathways and Therapeutic Implication 147
A case of sarcoidosis mimicking recurrences of endometrial cancer. 139
Cystoid macular edema secondary to paclitaxel therapy for ovarian cancer: A case report 133
A phase II study: dose-dense carboplatin and paclitaxel as neoadjuvant chemotherapy in locally advanced cervical cancer 120
Rapid growth of myxoid leiomyosarcoma of the vulva during pregnancy: a case report 119
Goblet-cell carcinoid of the ovary: A case report with ultrastructural analysis 119
Chronic Endometritis, a Common Disease Hidden Behind Endometrial Polyps in Premenopausal Women: First Evidence From a Case-Control Study. 116
A rare case of choroidal metastasis presented after conservative management of endometrial cancer 109
Human ovarian cancer tissue exhibits increase of mitochondrial biogenesis and cristae remodeling 102
Inflammatory Indexes as Prognostic and Predictive Factors in Ovarian Cancer Treated with Chemotherapy Alone or Together with Bevacizumab. A Multicenter, Retrospective Analysis by the MITO Group (MITO 24) 101
NEOADJUVANT CHEMOTHERAPY (NACHT) FOR LOCALLY ADVANCED CERVICAL CANCER (LACC): OUR EXPERIENCE WITH TIP (TAXOL+IFOSFAMIDE+PLATINUM) REGIMEN 99
Pseudo-Meigs syndrome and elevated Ca125 associated with struma ovarii 98
Prognostic Factors and Outcomes in 28 Cases of Uterine Leiomyosarcoma 98
Experience With First Level Ultrasound And Echocardiography For A Selected And An Unselected Population. 98
An unusual presentation of struma ovarii mimicking a malignant process 95
Carcinosarcoma of the vulva: a case report 95
Malignant Mixed Müllerian Tumour of the Uterus: Analysis of 44 Cases 94
Brain metastases in patients with EOC: Clinico-pathological and prognostic factors. A multicentric retrospective analysis from the MITO group (MITO 19) 93
Tumor Size, Histology and Smoking Are Prognostic in the Treatment of Small-Cell Cervical Carcinoma 90
Mitochondrial DNA content and mass increase in progression from normal to hyperplastic to cancer endometrium. 89
A case of Sertoli-Leydig cell tumor in a postmenopausal woman 88
Hysteroscopic evaluation of menopausal patients with sonographically atrophic endometrium. 88
Borderline epithelial tumors of the ovary: experience of 55 patients 86
BONE METASTASES AS PRESENTING SIGN OF MAMMARY-LIKE VULVAR ADENOCARCINOMA 86
GROIN RECURRENCE IN CARCINOMA OF THE VULVA: MANAGEMENT AND OUTCOME 85
Locally-advanced cervical cancer associated with complete uterine prolapse 85
Adjuvant chemotherapy does not improve disease-free survival in FIGO stage IC ovarian granulosa cell tumors: The MITO-9 study 85
Mitochondrial Dysfunctions in Type I Endometrial Carcinoma: Exploring Their Role in Oncogenesis and Tumor Progression 85
Molecular biomarkers predicting early development of endometrial carcinoma: A pilot study 85
A case of sarcoidosis mimicking recurrences of endometrial cancer. 84
null 83
The PGC-1a-dependent pathway of mitochondrial biogenesis is upregulated in type I endometrial cancer. 81
Antimicrobial prophylaxis in vaginal gynecologic surgery: a prospective randomized study comparing amoxicillin-clavulanic acid with cefazolin 81
Unsuspected diagnosis of uterine leiomyosarcoma after laparoscopic myomectomy 81
US and MR Findings in Primary Vaginal Leiomyoma: A Case Report. 81
Choice of cesarean section and perception of legal pressure 81
Small cell carcinoma of the uterine cervix metastasising to the cerebellum 81
Biological Pathways Involved in Tumor Angiogenesis and Bevacizumab Based Anti-Angiogenic Therapy with Special References to Ovarian Cancer 81
Sharing real-world experiences to optimize the management of olaparib toxicities: a practical guidance from an Italian expert panel 81
Differences in prognostic molecular markers between women over and under 45 years of age with advanced ovarian cancer 80
Oral altretamine used as salvage therapy in recurrent ovarian cancer 80
Ultrasound presurgical staging in endometrial cancer. 80
Chemotherapy in Recurrent Vulvar Carcinoma: A Phase II Study Using Combination of Cisplatin and Vinorelbine 79
Stages III and IV invasive epithelial ovarian carcinoma in younger versus older women: What prognostic factors are important? 77
Unsuspected diagnosis of uterine leiomyosarcoma after laparoscopic myomectomy. 76
Non-puerperal uterine inversion due to uterine sarcoma 75
null 74
Leptomeningeal involvement after remission of brain metastases from ovarian cancer. 74
Prognostic factors responsible for survival in sex cord stromal tumors of the ovary - A multivariate analysis 73
null 73
Pregnancy related cancer in Apulia. A population based linkage study. 73
Olaparib as maintenance therapy in patients with BRCA 1–2 mutated recurrent platinum sensitive ovarian cancer: Real world data and post progression outcome 73
Mast cell density, angiogenesis, blood clotting, and prognosis in women with advanced ovarian cancer 72
Significance of comprehensive surgical staging in noninvasive papillary serous carcinoma of the endometrium 71
Borderline epithelial tumors of the ovary 71
Bowel Dysfunction following Nerve-Sparing Radical Hysterectomy for Cervical Cancer: A Prospective Study. 71
Mimic of vulvar cancer: primary vaginal squamous carcinoma on cystocele 70
null 70
Central nervous system metastases from epithelial ovarian cancer: prognostic factors and outcomes. 70
The diagnostic role of "in utero" magnetic resonance imaging 69
Lymphadenectomy versus no lymphadenectomy in endometrial carcinoma: a retrospective analysis of 410 patients. 69
Resectoscopic Metroplasty with Uterine Septum Excision: A Histologic Analysis of the Uterine Septum 69
Unsuspected Diagnosis of Uterine Leiomyosarcoma after Laparoscopic Myomectomy 68
null 68
Lymphadenectomy versus no lymphadenectomy in endometrial carcinoma: A retrospective analysis of 410 patients 68
MALIGNANT MIXED MÜLLERIAN TUMOUR (MMMT) OF THE UTERUS: ANALYSIS OF 44 CASES 68
Trabectedin as single agent in the salvage treatment of heavily treated ovarian cancer patients: A retrospective, multicenter study 67
Hysteroscopic Evaluation Of Menopausal Women With Endometrial Thickness Of 4 Mm Or More. 67
BRCA1/2 MUTATIONS AND ‘’FOUNDER EFFECT’’ : THE CASE OF APULIA 67
Chemoradiation: A new approach for the treatment of cervical cancer 67
null 66
Paget disease of the vulva an analysis of 24 cases 66
null 65
Survival outcomes in patients with recurrent ovarian cancer who were treated with chemoresistance assay-guided chemotherapy 65
null 64
null 64
Benign metastasizing leiomyoma in the lung: a case report 64
A longitudinal study of the cervix in the third trimester of pregnancy by transvaginal ultrasound 64
null 64
A Longitudinal Study Of The Cervix Length In The Third Trimester Of Pregnancy By Transvaginal Ultrasound. 63
The importance of vascular immune regulation in the prognosis of women with advanced ovarian cancer 63
null 63
null 61
Aggressive angiomyxoma of the pelvis. A case report. 61
DOSE-DENSE WEEKLY CARBOPLATIN AND PACLITAXEL AS NEOADJUVANT CHEMOTERAPY IN LOCALLY ADVANCED CERVICAL CANCER 61
Acute Urinary Retention Due To Uterine Myoma: A Clinical Case. Arch Ital Urol Androl 60
null 59
Beyond BRCA1/2: Homologous Recombination Repair Genetic Profile in a Large Cohort of Apulian Ovarian Cancers 59
A case of acute lymphoblastic leukaemia mimicking an ovarian malignant tumor 58
null 58
Platinum-based neoadjuvant chemotherapy in locally advanced cervical carcinoma. 57
[Clinical experience with uterine sarcoma]. FT Esperienza clinica sui sarcomi uterini 57
Increased serum beta-HCG levels for 5 years before clinical diagnosis of ovarian dysgerminoma 56
Asfissia perinatale e problemi medico-legali 56
Neoadjuvant chemotherapy for stage III and IV epithelial ovarian cancer: A comparative study 56
“Medicina Difensiva” Nella Scelta Del Taglio Cesareo. ” 55
[Acute urinary retention in uterine myoma: description of a case]. FT Ritenzione urinaria acuta da mioma uterino: descrizione di un caso 55
Neoadjuvant chemotherapy for stage III and IV epithelial ovarian cancer: a comparative study. 55
LYMPHOVASCULAR SPACE INVASION IN PATIENTS WITH EARLY STAGE ENDOMETRIOID ADENOCARCINOMA OF THE ENDOMETRIUM: THE ROLE OF ADJUVANT THERAPY 53
Risk factors of congenital heart disease in the fetus of insulin-dependent diabetic mother 53
Totale 7.772
Categoria #
all - tutte 65.490
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 65.490


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.002 0 0 0 0 318 215 355 216 358 162 303 75
2020/20212.145 215 109 194 114 218 187 241 121 216 278 141 111
2021/20221.620 77 188 16 110 51 115 30 115 78 104 265 471
2022/20232.795 392 226 167 260 366 359 26 323 491 21 91 73
2023/20241.103 73 210 69 100 123 286 30 56 8 25 16 107
2024/2025788 129 48 338 182 91 0 0 0 0 0 0 0
Totale 13.739